BioPharma Dive 24 nov. 2025 Biogen strikes deal with Versant-backed biotech to expand immune portfolio #Dayra Therapeutics #Versant-backed biotech
BioPharma Dive 21 nov. 2025 A brain biotech’s top drug fails against MS #Contineum Therapeutics #Therapeutics dipped